Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126191411 | 12619141 | 1 | I | 20160728 | 20160803 | 20160803 | EXP | BR-GLAXOSMITHKLINE-BR2016GSK110652 | GLAXOSMITHKLINE | 0.00 | F | Y | 28.00000 | KG | 20160803 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126191411 | 12619141 | 1 | PS | Flixotide (CFC-free) | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | U | 21433 | 2 | DF | BID | ||||||
| 126191411 | 12619141 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | U | 0 | 2 | DF | OROMUCOSAL SPRAY | BID | |||||
| 126191411 | 12619141 | 3 | SS | Aerolin | ALBUTEROL | 1 | UNK | U | 0 | OROMUCOSAL SPRAY |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126191411 | 12619141 | 1 | Asthma |
| 126191411 | 12619141 | 2 | Asthma |
| 126191411 | 12619141 | 3 | Asthmatic crisis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126191411 | 12619141 | OT |
| 126191411 | 12619141 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126191411 | 12619141 | Asthmatic crisis | |
| 126191411 | 12619141 | Overweight |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |